PCN94 Comparative Analysis of Cost-Effectiveness Bevacizumab + Paclitaxel Versus Using Only Versus Paclitaxel as First Line Treatment of Patients with Metastatic Breast Cancer in the IMSS (Mexican Institute of Social Security)

✍ Scribed by Arreola Ornelas, H.; Rosado Buzzo, A.; García, L.; Camacho, L.M.; Lechuga, D.

• Book ID: 122108514
• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 61 KB
• Volume: 14
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2011.08.1195